By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
usatimeaheadusatimeaheadusatimeahead
  • Home
  • USA
  • World
  • Politics
  • Business
    • CEO
    • Founder
    • Journalist
    • Entrepreneur
    • Realtor
  • Health
    • Doctor
    • Plastic surgeon
    • Beauty cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
  • Economy
  • Lifestyle
Reading: Stock to buy today: Divi’s Laboratories (₹6,215.55) – BUY
Share
Font ResizerAa
Font ResizerAa
usatimeaheadusatimeahead
  • Home
  • USA
  • World
  • Politics
  • Business
  • Health
  • Sports
  • Economy
  • Lifestyle
Search
  • Home
  • USA
  • World
  • Politics
  • Business
    • CEO
    • Founder
    • Journalist
    • Entrepreneur
    • Realtor
  • Health
    • Doctor
    • Plastic surgeon
    • Beauty cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
  • Economy
  • Lifestyle
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Home » Blog » Stock to buy today: Divi’s Laboratories (₹6,215.55) – BUY
Business

Stock to buy today: Divi’s Laboratories (₹6,215.55) – BUY

Michael Thompson
By Michael Thompson
1 Min Read
Share

The short -term perspective is optimistic for Divi laboratories. The price action since December indicates a formation of Pattert Flag. This is a bullish continuation pattern. The 5 percent increase on Thursday confirms the rupture of this pattern. The support is now in the ₹ 5,900-5,800 region that can limit the disadvantage. It is likely that intermediate dives see new buyers to the market around this support zone.

The price of divi laboratory shares can increase to ₹ 7,300 in a month or two. Merchants can buy Divi laboratories now at ₹ 6,215. Accumulate the immersions at ₹ 6,110. Keep the stop-loss in ₹ 5,760. Sine the stop-loss to ₹ 6,350 as soon as the action rises to ₹ 6,550. Move the stop-loss up to ₹ 6,650 and ₹ 6,850 when the price of the action touches ₹ 6,800 and ₹ 7000 respectively. Leave the long positions to ₹ 7,100.

Video Credit: Businessline

Note: Recommendations are based on technical analysis. There is a risk of loss in trade

Posted on April 25, 2025

Previous Article 4/23: CBS Evening News Plus
Next Article Why the Titans picked Cam Ward, and what he needs to fix

Latest News

Excellence in Healthcare: Mass General Brigham Hospitals Lead National Rankings
Health
Robert Redford: The Lasting Legacy of a Hollywood Icon Who Redefined Cinema
USA
2025 Emmy Awards Winners Announced
Lifestyle
Michael McCaul to Not Seek Re-election
Politics
  • USA
  • World
  • Politics
  • Lifestyle
  • Economy
  • Sports
  • Business
  • CEO
  • Founder
  • Journalist
  • Realtor
  • Coach
  • Health
  • Doctor
  • Plastic surgeon
  • Beauty cosmetics
  • Fitness trainer
© 2017-2025 USA timeahead. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?